Trade ABCL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AbCellera Biologics Inc. Common Shares (ABCL) is trading at US$11.11, down 0.55% today as of Sep 15, 11:07 EDT. The company has a market capitalisation of US$3.67B. Over the past 52 weeks, ABCL has traded between US$2.75 and US$12.58. On Syfe you can trade ABCL with $0 commission and add it to your watchlist.
| Previous close | US$11.17 |
|---|---|
| Market cap | US$3.67B |
| 52-week range | US$2.75 – US$12.58 |
| Volume | 4.44M |
| Exchange | US |
Add to Watchlist
Set Price Alert
AbCellera Biologics Inc. Common Shares
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Year: 2020
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Producer Inflation Data Release
Aug 13, 1:13 PM · MT Newswires
AbCellera Biologics Prices $200 Million Offering of Shares, Pre-Funded Warrants
Aug 13, 8:14 AM · MT Newswires
AbCellera Biologics Launches $200 Million Public Offering
Aug 11, 9:31 PM · MT Newswires
Sector Update: Healthcare Stocks Edge Higher Premarket Monday
Aug 10, 1:18 PM · MT Newswires
AbCellera Biologics' ABCL635 Meets Primary Efficacy Endpoints in Phase 2 Study
Aug 10, 12:09 PM · MT Newswires
Stay on top of ABCL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
